Clinical Trials in Netherlands

• Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation
  2024-514991-41-01 Phase II Upper Tract Urothelial Carcinoma. Upper urinary tract transi… European Uro-Oncology Group Stichting
• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/… Not authorised
  2022-500410-26-00 Phase III Cystic Fibrosis University Medical Center Utrecht
• Treatments of COVID-19 in primary care in the Netherlands Not authorised
  2022-500678-33-00 Phase IV Patients with COVID-19 in the community, referred by their g… Maastricht University
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised
  2022-501006-34-00 Phase III Liver cirrhosis European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 Phase III Locally Advanced or Metastatic Cholangiocarcinoma Servier Affaires Medicales
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• SAFEST Not authorised
  2022-502059-79-00 Phase IV Ischemic stroke or transient ischemic attack Amsterdam UMC
• A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised
  2022-502099-22-00 Phase III HIV-1 Infection Merck Sharp & Dohme LLC
• Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Not authorised
  2022-502968-20-01 Phase II Idiopathic Inflammatory Myopathies University Medical Center Utrecht
• Baricitinib for treating hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international phase II … Not authorised
  2023-503480-42-00 Phase II/III Hospital-acquired pneumonia Centre Hospitalier Universitaire De Nantes
• A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Not authorised
  2023-503631-18-00 Phase III Nervous system diseases Sanofi-Aventis Research & Development
• PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Not authorised
  2023-503686-26-00 Phase I/II Progressive Pulmonary Fibrosis (PPF) St Antonius Hospital
• ASPIRE-1: dApagliflozin SC0062 and Prevention of renal Injury; a Randomized Evaluation Not authorised
  2023-504404-28-00 Phase II Chronic Kidney Disease University Medical Center Groningen
• Treating discharge and discomfort of eye prosthesis: a comparison between vitamin A ointment, anti-inflammatory eye drops and standard eye d… Not authorised
  2023-504451-27-00 Phase IV Chronic mucopurulent discharge and/or discomfort of the ocul… Amsterdam UMC
• Improving inpatient GHB detoxification with baclofen Not authorised
  2023-506167-34-00 Phase II GHB use disorder Stichting Radboud University Medical Center
• Metal Panel Patch Test Not authorised
  2023-507972-35-00 Phase III Allergic contact dermatitis Eczema Smarthealth Inc.
• 18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study Not authorised
  2023-508066-15-00 Phase II Hormone-positive breast cancer University Hospital Maastricht
• RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Not authorised
  2024-511580-28-00 Phase III PASC: post-acute sequelae of SARS-CoV-2 infection Universitair Medisch Centrum Utrecht
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI… Not authorised
  2024-514693-47-00 Phase III/IV EGFR mutated locally advanced or metastatic non-small cell l… Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with… Not authorised
  2024-515199-10-00 Phase II Retinitis Pigmentosa Laboratoires Thea
• A study to find how well LY3884961 works and how safe it is in participants with Parkinson’s disease Not authorised
  2024-519587-40-00 Phase I (FiH) Parkinson’s Disease with at Least One GBA1 Mutation Prevail Therapeutics Inc.
• Microdosing for ADHD and emotion regulation Not authorised
  2025-520906-36-00 Phase II Attention Deficit Hyperactivity Disorder (ADHD) Universiteit Maastricht
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 Phase III Schizophrenia European Group for Research in Schizophrenia Stichting
• Research into existing medicines to reduce aging, pain, and inflammation in osteoarthritis. Not authorised
  2025-524885-12-00 Phase II Osteoarthritis Radboud universitair medisch centrum Stichting

Showing 1–24 of 2,543 trials